Gladys Nunez
Director/Board Member at Enclear Therapies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anthony R DePasqua | M | - |
Enclear Therapies, Inc.
 Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | - |
| Jonathan Fleming | M | 66 |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | - |
| Kasper Roet | M | - |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | - |
| William B. Gormley | M | - |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | - |
| Hillel Bachrach | M | 78 |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | 4 years |
| Zafrira Avnur | M | 73 |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | 4 years |
| Jason Camm | M | 35 |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | 4 years |
| Laura Paulsen | F | - |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pamela A. Jones | F | - |
Marist College
| 6 years |
| Wing Sin Hui | M | 51 |
The University of Southampton
| 6 years |
| Marcelino Botín-Sanz de Sautuola | M | 62 |
The University of Southampton
| 4 years |
| Tom Almond | M | - |
The University of Southampton
| 4 years |
| Adam Alexander Crisp | M | 50 |
The University of Southampton
| 4 years |
| Brian McLaughlin | M | - |
Marist College
| 4 years |
| Philip Anderson | M | - |
The University of Southampton
| 4 years |
| Thomas James McGimpsey | M | - |
Marist College
| 4 years |
| A. Stamou | M | - |
The University of Southampton
| 1 years |
| Wing Ho Ngan | M | 50 |
The University of Southampton
| 4 years |
| Mark Volanthen | M | - |
The University of Southampton
| 4 years |
| Diego Alvarez-Blanco | M | - |
The University of Southampton
| 3 years |
| Eric Chapman | M | - |
The University of Southampton
| 4 years |
| Robin Vincent Preston | M | - |
The University of Southampton
| 3 years |
| Jason Valentino | M | - |
Marist College
| 4 years |
| Feng Lian Xu | M | - |
The University of Southampton
| 3 years |
| Joe Panettieri | M | - |
Marist College
| 4 years |
| Izmet Iskandar Bin Mohd Ramli | M | 53 |
The University of Southampton
| 4 years |
| Christie Kinney | F | - |
Marist College
| 4 years |
| Peter Lourensz | M | - |
The University of Southampton
| 3 years |
| Maria Haggerty | F | - |
Marist College
| 4 years |
| Randy Lehman | M | - |
Marist College
| 4 years |
| Sergei Sivoplias | M | - |
The University of Southampton
| 1 years |
| Greg Bibb | M | - |
Marist College
| 4 years |
| Andrew Ira Clinton | M | 53 |
Marist College
| 4 years |
| Karen Meidlinger | M | - |
The University of Southampton
| 3 years |
| John Edward Wenham Meredith | M | 85 |
The University of Southampton
| 1 years |
| Zoran Milojevic | M | - |
Marist College
| 4 years |
| James Garland | M | - |
The University of Southampton
| 4 years |
| Roberto R. Garcia | M | - |
Marist College
| 2 years |
| David Srodzinski | M | - |
The University of Southampton
| 2 years |
| Michael McCormick | M | - |
Marist College
| 4 years |
| Jason Lawford | M | 49 |
The University of Southampton
| 3 years |
| Alex Da Costa | M | - |
The University of Southampton
| 3 years |
| Yeong Ching Tan | M | 50 |
The University of Southampton
| 4 years |
| Eamon J. Twomey | M | - |
Marist College
| 4 years |
| Phil T. Frank | M | - |
Marist College
| 4 years |
| Jamie McGurk | M | - |
Marist College
| 4 years |
| Paul D. Robinson | M | - |
The University of Southampton
| 4 years |
| Martin Nes | M | 55 |
The University of Southampton
| 3 years |
| Marcus Kern | M | - |
The University of Southampton
| 1 years |
| Joseph W. Hagan | M | - |
Marist College
| 4 years |
| Chris Ayton | M | - |
The University of Southampton
| 3 years |
| Roger Ardan | M | - |
Marist College
| 4 years |
| Max Rossi | M | - |
Marist College
| 4 years |
| Vincent Amatulli | M | - |
Marist College
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 28 | 51.85% |
| United Kingdom | 26 | 48.15% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gladys Nunez
- Personal Network
